| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |